Viewing Study NCT06525363



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06525363
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-24

Brief Title: Clinical Assessment of Chitosan Nanoparticles on Periodontal Problems Post Steroidal Inhalation in Asthmatic Patients Phase I Trial
Sponsor: None
Organization: None

Study Overview

Official Title: Clinical Assessment of Chitosan Nano-particles on Periodontal Problems Post Steroidal Inhalation in Asthmatic Patients Phase I Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Periodontal problems management is the most important goals of chronic asthmatic patients that adapted to use steroid inhalation for long time Gram negative anaerobic bacteria are generally suggested as the primary cause of Periodontal problems and mechanical procedure is the treatment approach which is performed nonsurgical or surgically The understanding of the role of bacteria in the initiation and progression of periodontal disease has led to great interest in the use of antibiotics to suppress or eradicate pathogenic macrobiotic Systemic antibiotics have been used in different forms of periodontal disease treatment Systemic antibiotics can penetrate soft tissues and may target invasive organisms can be used to treat multiple sites simultaneously and may also affect reservoirs of bacterial reinfection such as saliva the tonsils and the oral mucosa However there may be problems associated with the use of systemic antibiotics such as the development of resistant bacteria and potential side effects hypersensitivity reactions gastrointestinal discomfort etc so in this study we aimed at To evaluate the effect of chitosan nanoparticle spray in management of dental problems in asthmatic patients receiving corticosteroids inhaler that support the growth of bacteria in periodontal area
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None